Relative overall mRNA expression of TACR1 splice variants led us to question the mechanism through which AP exhibits its significant anti-proliferative effect on pancreatic cancer cells, which we expected to be mediated by the SP/NK1R complex. The gene discussed is TFF2; the disease is familial pancreatic carcinoma.